AXON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Axon Enterprise is not a strong buy right now for a Beginner investor focused on long-term holding. The business quality and growth remain excellent, but the current setup is mixed: the stock is trading below its pivot and under bearish moving averages, while analysts have recently cut price targets across the board. Since the user is impatient and does not want to wait for a better entry, I would still not buy here; I would hold off until the trend improves or the stock reclaims key resistance.
AXON closed at 391.804, down 2.16% during regular trading, and remains below the pivot at 397.201. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which indicates the current price trend is still weak despite the longer-term uptrend story. MACD histogram is positive at 1.728 but contracting, suggesting momentum is fading rather than strengthening. RSI_6 is 45.368, which is neutral and does not show a compelling oversold entry. Key support is at 371.699 and then 355.944, while resistance is 422.704 and 438.459. The stock trend model shows only a modest near-term edge, not a strong breakout setup.
News remains fundamentally supportive: Axon Vision is generating measurable customer savings, annual recurring revenue growth over two years is 37.6%, and EPS growth over two years is 26.6%, all of which point to strong long-term business execution. Analysts still largely maintain bullish ratings such as Overweight, Buy, and Outperform despite lowering targets. Goldman noted diversification beyond core domestic law enforcement, and several firms cited strong Q1 execution, new AI products, drones, and raised revenue guidance. Hedge funds are heavily buying, with reported buying up 1255.57% over the last quarter.
Recent analyst target cuts are substantial across multiple firms, with Barclays, Morgan Stanley, Goldman Sachs, Baird, UBS, Piper Sandler, Citizens, and TD Cowen all lowering targets. UBS is neutral and flagged concerns around AI and free cash flow, and Citizens noted tempered free cash flow expectations and a flat adjusted EBITDA margin outlook. Technically, the stock is still under bearish moving averages and below pivot. Insider activity is neutral, and there is no recent congress trading data or politically driven buying support.
Latest quarter financials were not fully provided due to a data error, so the specific quarter season cannot be confirmed from the dataset. However, the available operating trend data is strong: annual recurring revenue growth is 37.6% over the past two years, and EPS growth is 26.6% over the past two years. Recent analyst commentary also says Q1 results were solid, revenue guidance was raised, and AI plus drones are leading growth. This suggests the latest quarter was fundamentally healthy from a growth perspective, even if margin and free cash flow concerns remain.
Wall Street remains broadly positive but less enthusiastic on valuation than before. Most firms kept Overweight/Buy/Outperform ratings, but price targets were cut meaningfully, showing reduced upside expectations. The bull case centers on strong growth, product innovation, AI and drone expansion, and business diversification. The bear case centers on weaker free cash flow visibility, flat EBITDA margin outlook, and the stock’s premium positioning. Overall, pros still outweigh cons on business quality, but the recent target cuts and mixed technicals make this a hold rather than a buy today.
